{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:03Z","timestamp":1787020923033,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acquired long QT syndrome is an important and preventable cause of cardiac arrest. Certain medications and electrolyte disturbance are common contributors, and often coexist. In this case, we report five contributors to cardiac arrest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This case is of a 51-year-old Caucasian female patient who presented with vomiting associated with hypokalemia and hypomagnesemia. She subsequently received ondansetron and metoclopramide, on the background of chronic treatment with fluoxetine. She then suffered an in-hospital monitored cardiac arrest, with features of long QT and torsades de pointes retrospectively noted on her prearrest electrocardiogram. She was diagnosed with acquired long QT syndrome, and her QT interval later normalized after removal of offending causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the importance of proper consideration prior to prescribing QT prolonging medications, especially in patients who have other risk factors for prolonged QT, such as electrolyte disturbances and pretreatment with QT prolonging medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-021-03204-7","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T19:03:50Z","timestamp":1641841430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Vomiting, electrolyte disturbance, and medications; the perfect storm for acquired long QT syndrome and cardiac arrest: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"K. D.","family":"Tiver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dharmaprani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. X.","family":"Quah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"Waddell-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-3025","authenticated-orcid":false,"given":"A. N.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"4","key":"3204_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","volume":"5","author":"PJ Schwartz","year":"2012","unstructured":"Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5(4):868\u201377.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"3204_CR2","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.hlc.2016.01.020","volume":"25","author":"KE Waddell-Smith","year":"2016","unstructured":"Waddell-Smith KE, Skinner JR, C.G.C.W.G. members of the. Update on the diagnosis and management of familial long QT syndrome. Heart Lung Circ. 2016;25(8):769\u201376.","journal-title":"Heart Lung Circ"},{"issue":"3","key":"3204_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/europace\/eur372","volume":"14","author":"LC Wong","year":"2012","unstructured":"Wong LC, Behr ER. Acquired long QT syndrome: as risky as congenital long QT syndrome? Europace. 2012;14(3):310\u20131.","journal-title":"Europace"},{"issue":"2","key":"3204_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.15420\/aer.2019.8.3","volume":"8","author":"N El-Sherif","year":"2019","unstructured":"El-Sherif N, Turitto G, Boutjdir M. Acquired long QT syndrome and electrophysiology of Torsade de Pointes. Arrhythm Electrophysiol Rev. 2019;8(2):122\u201330.","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"6","key":"3204_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2165\/11598160-000000000-00000","volume":"35","author":"JE Tisdale","year":"2012","unstructured":"Tisdale JE, et\u00a0al. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs. Drug Saf. 2012;35(6):459\u201370.","journal-title":"Drug Saf"},{"issue":"7","key":"3204_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.hrthm.2017.03.014","volume":"14","author":"H Yu","year":"2017","unstructured":"Yu H, et\u00a0al. Acquired long QT syndrome in hospitalized patients. Heart Rhythm. 2017;14(7):974\u20138.","journal-title":"Heart Rhythm"},{"issue":"4","key":"3204_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1124\/pr.110.003723","volume":"62","author":"P Kannankeril","year":"2010","unstructured":"Kannankeril P, Roden DM, Darbar D. Drug-induced long QT syndrome. Pharmacol Rev. 2010;62(4):760\u201381.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"3204_CR8","first-page":"233","volume":"18","author":"N El-Sherif","year":"2011","unstructured":"El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J. 2011;18(3):233\u201345.","journal-title":"Cardiol J"},{"key":"3204_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcvm.2015.00026","volume":"2","author":"PE Lazzerini","year":"2015","unstructured":"Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT syndrome: an emerging role for inflammation and immunity. Front Cardiovasc Med. 2015;2:26.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3204_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2125.2008.03229.x","volume":"66","author":"M Molokhia","year":"2008","unstructured":"Molokhia M, et\u00a0al. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. Br J Clin Pharmacol. 2008;66(3):386\u201395.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"3204_CR11","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","volume":"121","author":"BJ Drew","year":"2010","unstructured":"Drew BJ, et\u00a0al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047\u201360.","journal-title":"Circulation"},{"issue":"9","key":"3204_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/clc.20945","volume":"34","author":"GC Digby","year":"2011","unstructured":"Digby GC, et\u00a0al. Acquired long QT interval: a case series of multifactorial QT prolongation. Clin Cardiol. 2011;34(9):577\u201382.","journal-title":"Clin Cardiol"},{"issue":"3","key":"3204_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/bcp.12726","volume":"81","author":"SH Thomas","year":"2016","unstructured":"Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81(3):420\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"3204_CR14","unstructured":"MIMS online. Ondansetron MIMS Full Product Information. 2020. https:\/\/www-mimsonline-com-au.salus.idm.oclc.org\/Search\/FullPI.aspx?ModuleName=Product%20Info%26searchKeyword=ondansetron%26PreviousPage=~\/Search\/QuickSearch.aspx%26SearchType=%26ID=90140001_2#Precautions8812"},{"key":"3204_CR15","unstructured":"Administration TG. Ondansetron consumer medicines information. 2021. https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2009-CMI-00741-3&d=202104011016933."},{"key":"3204_CR16","unstructured":"Administration TG. Australian product information APO-fluoxetine. 2018. https:\/\/www.ebs.tga.gov.au\/ebs\/picmi\/picmirepository.nsf\/pdf?OpenAgent&id=CP-2010-PI-01265-3."},{"issue":"10","key":"3204_CR17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1177\/1060028013501994","volume":"47","author":"KA Funk","year":"2013","unstructured":"Funk KA, Bostwick JR. A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother. 2013;47(10):1330\u201341.","journal-title":"Ann Pharmacother"},{"key":"3204_CR18","unstructured":"Australian Institute for Health and Welfare. Mental health services in Australia. 2021. https:\/\/www.aihw.gov.au\/reports\/mental-health-services\/mental-health-services-in-australia\/report-contents\/mental-health-related-prescriptions."},{"issue":"2","key":"3204_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jsps.2018.11.003","volume":"27","author":"FM Fernandes","year":"2019","unstructured":"Fernandes FM, et\u00a0al. Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to intensive care units. Saudi Pharm J. 2019;27(2):229\u201334.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"3204_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2036.2003.01641.x","volume":"18","author":"E Ellidokuz","year":"2003","unstructured":"Ellidokuz E, Kaya D. The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers. Aliment Pharmacol Ther. 2003;18(1):151\u20135.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3204_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/europace\/eut214","volume":"16","author":"G Sarganas","year":"2014","unstructured":"Sarganas G, et\u00a0al. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany. Europace. 2014;16(1):101\u20138.","journal-title":"Europace"},{"key":"3204_CR22","unstructured":"CredibleMeds.com. CredibleMeds. 2014. https:\/\/www.crediblemeds.org\/blog\/two-medicines-added-tdp-conditional-risk-list\/."},{"issue":"13","key":"3204_CR23","first-page":"e272","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, et\u00a0al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):e272\u2013391.","journal-title":"Circulation"},{"issue":"3","key":"3204_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/europace\/eur316","volume":"14","author":"G Monnig","year":"2012","unstructured":"Monnig G, et\u00a0al. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up. Europace. 2012;14(3):396\u2013401.","journal-title":"Europace"},{"key":"3204_CR25","doi-asserted-by":"publisher","first-page":"616866","DOI":"10.3389\/fphys.2020.616866","volume":"11","author":"D Dharmaprani","year":"2020","unstructured":"Dharmaprani D, et\u00a0al. M\/M\/infinity birth-death processes\u2014a quantitative representational framework to summarize and explain phase singularity and wavelet dynamics in atrial fibrillation. Front Physiol. 2020;11:616866.","journal-title":"Front Physiol"},{"issue":"12","key":"3204_CR26","doi-asserted-by":"publisher","first-page":"e007569","DOI":"10.1161\/CIRCEP.119.007569","volume":"12","author":"D Dharmaprani","year":"2019","unstructured":"Dharmaprani D, et\u00a0al. Renewal theory as a universal quantitative framework to characterize phase singularity regeneration in mammalian cardiac fibrillation. Circ Arrhythm Electrophysiol. 2019;12(12):e007569.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"3204_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.15420\/aer.2020.42","volume":"10","author":"JX Quah","year":"2021","unstructured":"Quah JX, Dharmaprani D, Lahiri A, Tiver K, Ganesan AN. Reconceptualising atrial fibrillation using renewal theory: a novel approach to the assessment of atrial fibrillation dynamics. Arrhythm Electrophysiol Rev. 2021;10:77\u201384.","journal-title":"Arrhythm Electrophysiol Rev"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03204-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03204-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T19:06:21Z","timestamp":1641841581000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03204-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3204"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03204-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}